BACK: IMAC Corp Market Cap to Revenue

Corporate company logo of IMAC Regeneration Centers (BACK)

A comprehensive non-surgical joint treatment method strengthens customer loyalty, which positively impacts the historical P/S ratio. Stable demand for physiotherapy and government insurance guarantees a steady cash flow, while local procurement of consumables mitigates logistical disruptions. The current value of 9.80 shows the level of this metric, reflecting the market valuation of IMAC Holdings, Inc. (BACK) revenue relative to its share price.

BACK: imacholdings.comm P/S Multiple 02/21/2024 - 04/05/2025

Metric breakdowns and analytics for IMAC Regeneration Centers (BACK)

- stock value and consensus price forecast:
Stock Price imacholdings.comm|BACK - Analyst Consensus Forecast
- market capitalization information:
Market Valuation IMAC Regeneration Centers|BACK - Real Price to Acquire Entire Company
- book value of equity indicators:
Accounting Value of a Share IMAC Holdings|BACK - Book Capitalization|Market Value to Book Value imacholdings.comm|BACK - Aggregate Company Assets
- business debt structure and liquidity details:
Debt to Capital IMAC Holdings, Inc.|BACK - Long-Term Debt to Equity|Short-Term Debt to Equity IMAC Corp|BACK - Company Aggregate Debts|Debt to Book Value Ratio IMAC Regeneration Centers|BACK - Company Long-Term Debts|Short-Term Debt Volume IMAC Holdings|Immediate Liquidity Ratio imacholdings.comm
- earnings and valuation multiples information:
BACK - Net Profit|Projected Net Profit IMAC Holdings, Inc.|BACK - Price to Earnings Ratio|Market Cap to Projected Earnings IMAC Holdings Inc|BACK - Price/Earnings to Growth Multiple|Business Value to Operating Income Before Depreciation IMAC Regeneration Centers|BACK - Operating profit EBITDA|Net earnings per share for the last four quarters IMAC Holdings|BACK - Earnings per share for the last twelve months|Year-over-year earnings per share growth for the last 12 months imacholdings.comm|BACK - Earnings growth in current year|Expected earnings per share growth for next year IMAC Holdings, Inc.
- issuer revenue and sales details:
BACK - Company Sales|Company Future Sales imacholdings.comm|BACK - P/S Multiple|Price-to-Projected Revenue Ratio IMAC Regeneration Centers
General company analysis:imacholdings.comm (BACK)
Mass-produced product of IMAC Corp

The P/S metric determines the market value of a single unit of revenue by correlating total market capitalization with sales volume to assess whether an asset is overvalued. By analyzing the capitalization-to-revenue ratio, an investor can gauge the expansion efficiency of IMAC Holdings, Inc. (BACK) within the US regenerative medicine sector, where the scaling pace of the outpatient center network must validate the high market valuation through actual growth in patient flow.

Competing companies

P/S Multiple hcahealthcare.com (HCA)|P/S Multiple THC (Tenet Healthcare Corporation)|FMS - Market Cap to Revenue|SOLV: Market Cap to Revenue|Market Capitalization-to-Revenue Ratio EHC (Encompass)|UHS: P/S Multiple|davita.com - Market Capitalization-to-Revenue Ratio|Price-to-Revenue Ratio RadNet|Price to Sales Option Care OPCH|Price-to-Revenue Ratio Surgery Partners Corp (SGRY)|Price-to-Revenue Ratio PINC (Premier Health)|P/S Multiple EYE (National Vision Holdings)|PGNY: Market Cap to Revenue Ratio|Ardent Health Partners - P/S Multiple|Price-to-Revenue Coefficient Select Medical Corporation SEM|Apollo Medical Holdings (ASTH) - Price-to-Revenue Ratio|Market Cap to Revenue Ratio MD|USPH (US Physical Therapy) - P/S Multiple|PNTG - Price-to-Revenue Multiple|Price-to-Revenue Ratio Organogenesis (ORGO)|Price-to-Revenue Coefficient Nutex Health Inc|Auna Health - Market Cap to Revenue|Market Capitalization-to-Revenue Ratio SBC|Evolus, Inc. - P/S Multiple|Price-to-Revenue Coefficient chs.net CYH|beautyhealth.com (SKIN) - Price-to-Revenue Ratio|Market Cap to Revenue Ratio MDWD|BTMD (Biote Corp) - P/S Multiple|Market Cap to Revenue The Joint (JYNT)|Market Cap to Revenue DCGO (DocGo Inc.)|Price-to-Revenue Coefficient p3hp.org|P/S Multiple GANX (Gain Therapeutics)|EUDA Health Holdings - Price-to-Revenue Ratio|Basel Medical Group Limited - P/S Multiple|CLGN - P/S Multiple|CUPR: P/S Multiple|Market Cap to Revenue concordmedical.com|Price-to-Revenue Ratio American Shared Hospital Services|P/S Multiple MEDIROM Healthcare Group Inc.|Market Cap to Revenue ALBT (Avalon GloboCare)|Market Cap to Sales Volume DHAI|Price-to-Revenue Ratio Longevity Health Holdings XAGE|Market Capitalization-to-Revenue Ratio NIVF|ATI Physical Therapy Corp - P/S Multiple|Price to Sales CareMax Inc.|KDLY: P/S Multiple|ModivCare Corp (MODV) - P/S Multiple|Market Cap to Revenue NVOS|SSY (SunLink Health Systems, Inc) - Market Cap to Sales Volume